|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.00 JPY | +3.39% |
|
0.00% | -21.79% |
| 05-14 | Ribomic Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 03-19 | Ribomic Files IND For Phase III Trial Of Achondroplasia Drug In Japan | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RIBOMIC INC. | Bio Therapeutic Drugs | +3.39% | 0.00% | -21.79% | -39.60% | -82.57% | 20.42M |  | | |
- Stock Market
- Stocks
- 4591 Stock
- Charts Ribomic Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
